Roger Berlin, MD

Roger is an Advisor & Principal of the New England Consulting Group, and a key member of our healthcare and consumer products practice teams.

Roger’s career spans 20 years in the healthcare industry.  During this time, he has served in a variety of substantial leadership roles, most recently CEO and Director of Arno Therapeutics, a biopharmaceutical company that develops innovative products for the treatment of cancer.   Roger is a recognized expert in global prescription and non-prescription pharmaceutical development. His experience spans multiple therapeutic areas, collaboration with commercial and government entities, extensive interaction with the FDA and with other regulatory authorities including the European Medicines Evaluation Authority.

Prior to his tenure at Arno he was President, Global R&D at Wyeth Consumer Healthcare where he also served on the divisional senior leadership team and served on the Consumer Health Products Association scientific leadership group.  Prior to Wyeth, Roger held a variety of senior leadership roles at Merck, including head of global clinical research operations where he oversaw a group of 225 staff conducting clinical trials in all therapeutic areas worldwide.  Roger was also integral in 3 inter-company collaborations, Yamanouchi, Astra and J&J*Merck, all of which let to successful marketed products.

Therapeutic expertise includes but is not limited to analgesia, sleep, urology, allergy, asthma, migraine, cough/cold, cholesterol reduction, nutrition and gastroenterology.  Numerous unique and first-ever claims and approvals resulted from work in these areas.

He serves(d) on the boards of rTerra (renewable energy company), Arno Therapeutics, the advisory board of Vigilon, the Life and Healthcare Advisory board of JRG Ventures, and the clinical advisory board of Alevium. He has published extensively, served as a reviewer to numerous journals and served on the national research committee of the American Gastroenterological Association.

Roger holds a B.S., Phi Beta Kappa, Magna Cum Laude, in Biology from Queens College, CUNY, an MD from Cornell-Weill Medical College and completed the Harvard Business School Advanced Management Program.